Skip to main content

Month: April 2021

[iliad press release] Procedures for participating in the Annual General Meeting on June 2, 2021

Press Release Paris, April 16, 2021 Procedures for participating in the Annual General Meeting on June 2, 2021   annual general meeting   iliad’s Board of Directors has called the Annual General Meeting for June 2, 2021 at 9:00 a.m. at the Company’s head office. In view of the Covid-19 restrictions currently in place in France concerning travel and group meetings, the Board of Directors has decided that the Annual General Meeting will, on an exceptional basis, be held virtually, i.e. without the physical attendance of shareholders and other eligible attendees. The agenda, proposed resolutions and main procedures for participating in and voting at the Annual General Meeting were published in the Bulletin des Annonces Légales et Obligatoires (the French legal gazette) today. The procedures for participating in the Annual General Meeting...

Continue reading

Auctions of mortgage covered bonds for the refinancing of RD Cibor6® and FlexKort®

ToNASDAQ Copenhagen A/S   Executive BoardLersø Parkalle 100DK-2100 København Øwww.rd.dk Telephone +45 7012 5300  16 April 2021Company Announcement number 33/2021 Auctions of mortgage covered bonds for the refinancing of RD Cibor6® and FlexKort® Realkredit Danmark will hold auctions on SDRO’s for the refinancing of RD Cibor6® and FlexKort® as of 1 July 2021. The auctions will be held on 26 – 27 May 2021. Realkredit Danmark will open a 4-year mortgage covered bond (SDRO) without an interest rate floor to put on the auctions for the refinancing of RD Cibor6®. The bond will be used for new loan offers at a later stage. At the auction, investors make their bids on the spread to CIBOR 6M. The characteristics of the new bond are listed in the appendix. The final terms will be published by announcement of prospectus as soon as they...

Continue reading

Auktioner over obligationer til refinansiering af RD Cibor6® og FlexKort®

TilNASDAQ Copenhagen A/S   DirektionenLersø Parkalle 1002100 København Øwww.rd.dk Telefon 7012 5300  16. april 2021Selskabsmeddelelse nummer 33/2021 Auktioner over obligationer til refinansiering af RD Cibor6® og FlexKort® Realkredit Danmark gennemfører auktioner over SDRO til refinansiering af RD Cibor6® og FlexKort® pr. 1. juli 2021. Auktionerne vil blive afholdt den 26. og 27. maj 2021. Til brug for auktionerne åbner Realkredit Danmark en ny 4-årig obligation uden rentegulv til refinansiering af RD Cibor6®. Obligationen vil på sigt blive anvendt som tilbudspapir. På auktionen skal investorer byde på tillægget til CIBOR 6M. Den nye obligations karakteristika fremgår af vedlagte bilag. De Endelige vilkår offentliggøres via prospektmeddelelse, så snart de foreligger. Til refinansiering af FlexKort® anvendes eksisterende ISIN, DK0004615713....

Continue reading

[Communiqué de presse iliad] Mise à disposition du document d’enregistrement universel (URD) pour l’exercice clos le 31 décembre 2020

Communiqué de presse Paris, le 16 avril 2021 Mise à disposition du document d’enregistrement universelExercice clos le 31 décembre 2020 information réglementée La Société iliad a déposé le 15 avril 2021 son document d’enregistrement universel 2020 auprès de l’Autorité des Marchés Financiers (AMF) sous le numéro D.21-0312. Ce document intègre notamment :le rapport financier annuel 2020 ; le rapport sur le gouvernement d’entreprise; la déclaration de performance extra-financière ; le descriptif du programme de rachat d’actions ; les rapports des commissaires aux comptes.Le document d’enregistrement universel est tenu gratuitement à la disposition du public dans les conditions prévues par la réglementation en vigueur. Il peut être consulté sur le site internet de la Société www.iliad.fr dans la rubrique « Investisseurs> Information réglementée>...

Continue reading

[iliad press release] French version of the 2020 Universal Registration Document now available

Press Release Paris, April 16, 2021 French version of the 2020 Universal Registration Document now available regulatory information  The French version of iliad’s 2020 Universal Registration Document (the “Document d’Enregistrement Universel”) was filed on April 15, 2021 with the French securities regulator (the Autorité des Marchés Financiers – AMF) under number D.21-0312. The Document d’Enregistrement Universel notably includes the following:the annual financial report for the 2020 fiscal year; the report on corporate governance; the non-financial performance statement; the description of the share buyback program; the Statutory Auditors’ reports.The Document d’Enregistrement Universel is available to the public free of charge in accordance with the applicable regulations. It can also be found on the Company’s website at www.iliad.fr...

Continue reading

CAAC Established EH216 Type Certification Team to Further Advance Certification Process

GUANGZHOU, China, April 16, 2021 (GLOBE NEWSWIRE) — EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company, today announced that the Civil Aviation Administration of China (“CAAC”) has established a “type certification” (“TC”) team for the EH216 passenger-grade AAV. The kickoff meeting was held in Guangzhou on April 13-14 with the aim to officially advance the TC approval work of EH216. This is unprecedented in CAAC’s record in TC approval projects for unmanned aerial system. At the kickoff meeting, expert members of the CAAC TC team investigated and evaluated the design features, technical points, safety performance and other aspects of the EH216, followed by a field trip to EHang’s Research and Development Center. The CAAC...

Continue reading

Constellium to Report First Quarter 2021 Results on April 28, 2021

PARIS, April 16, 2021 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) will host a conference call and webcast on Wednesday, April 28 at 11 a.m. (Eastern Daylight Time) to announce its first quarter 2021 results. The press release will be sent before market opening. The conference call will be hosted by Jean-Marc Germain, Chief Executive Officer, and Peter Matt, Executive Vice President and Chief Financial Officer. Details of the conference call, webcast and accompanying presentation will be available on the Constellium Investor Relations page at:https://www.constellium.com/financial-results-presentations The webcast can be accessed live at:https://edge.media-server.com/mmc/p/2ukrjzst To participate by telephone, please dial the following number and enter access code 1555229 to be connected to the Constellium earnings call:USA:...

Continue reading

Loop Insights Completes Acquisition of Passcreator – a growing German based mobile marketing technology Company

VANCOUVER, British Columbia, April 16, 2021 (GLOBE NEWSWIRE) — Further to the Company’s press release dated March 29, 2021, Loop Insights Inc. (TSXV: MTRX; OTCQB: RACMF) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick and mortar space, is pleased to announce the receipt of TSXV approval and completion, on April 14, 2021, of the acquisition of mediahelden GmbH d/b/a/ Passcreator by Loop. Due to rounding, the number of common shares of Loop issued as consideration was revised to 1,301,425, all other consideration paid as set out in the prior news release remains the same. About Passcreator Passcreator is a German wallet pass software company that offers clients a software as a service...

Continue reading

Relay Therapeutics Extends Leadership in Integrating Computational and Experimental Approaches to Create Precision Medicines by Acquiring ZebiAI

Relay Therapeutics’ leadership in this new breed of biotech positions the company as a strategic partner of choice for emerging technologies and founders in these fields ZebiAI amplifies Relay Therapeutics’ Dynamo™ platform with a library of industry-leading experimental DEL data sets and validated machine learning models deployed in hit finding and optimization of novel medicines Relay Therapeutics to host conference call at 8:00 a.m. ET CAMBRIDGE, Mass., April 16, 2021 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading edge computational and experimental technologies, today announced the acquisition of ZebiAI, a pioneer in applying massive experimental DNA encoded library data sets to power machine learning for drug...

Continue reading

CPI Aerostructures Reports Fourth Quarter 2020 Results

Fourth Quarter 2020 vs. Fourth Quarter 2019Revenue of $25.4 million compared to $22.7 million. Gross profit of $4.6 million compared to $2.5 million. Gross margin of 18.2% compared to 10.9%. Net income of $1.3 million compared to net loss of $(1.4) million. Earnings per diluted share of $0.11 compared to loss per diluted share of $(0.12). Cash flow from operations of $1.7 million compared to $3.7 million.Full Year 2020 vs. Full Year 2019Revenue of $87.6 million compared to $87.5 million. Gross profit of $12.1 million compared to $9.1 million. Gross margin of 13.8% compared to 10.4%. Net loss of $(1.3) million compared to a net loss of $(4.5) million. Loss per share of $(0.11) compared to a loss per share of $(0.38). Cash flow used by operations of $(1.6) million compared to a use of $(0.4) million. Total funded backlog of $169.6...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.